[{"Assets_0_Q2_USD":430965.0,"CommonStockSharesOutstanding_0_Q2_shares":9533290.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-650839.0,"NetIncomeLoss_1_Q2_USD":-918604.0,"NetIncomeLoss_2_Q2_USD":-1711785.0,"StockholdersEquity_0_Q2_USD":-1284152.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":9533290.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":9533290.0,"Ticker":"ENOB","CIK":"1527728","name":"DANDRIT BIOTECH USA, INC.","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170214"}]